| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3802048 | Medicina Clínica | 2007 | 5 Pages |
Abstract
A d4T dose reduction in an immuno-virologically stable population does not affect treatment efficacy. Longer follow-ups are required to confirm improvements in the safety profile.
Related Topics
Health Sciences
Medicine and Dentistry
Medicine and Dentistry (General)
Authors
Enric Pedrol, Teodoro MartÃn, Miguel Angel del Pozo, Juan Flores, José Sanz, José A. Cartón, Juan-José Jusdado, Piedad Arazo, Esteve Ribera, Elisabet Deig,